How BIQADX turns platform science into verifiable diagnostic confidence — layer by layer.
Layered evidence
We do not believe diagnostic trust should depend on black-box outputs alone. We believe trust must be built through layered evidence.
Across specimen intake, acoustofluidic conditioning, centrifugal execution, fluorescence and optical measurement, electrochemical sensing, air-gapped inference, and secure local reporting — we examine how the complete diagnostic chain behaves under controlled, interpretable conditions.
The BIQADX validation stack
Was the input biologically and physically fit for analysis?
Did routing, chemistry, and workflow phases occur correctly?
Was the signal stable, discriminative, and low-noise?
Was the output generated under the correct analytical context?
Was the result securely structured, traceable, and governance-ready?
Performance evaluation architecture
Signal discrimination, concentration behavior, drift direction, background control, repeatability planning.
Assay-platform fit, early performance behavior, workflow coherence, observation readiness, method-direction strength.
Workflow compatibility, validation maturity, and deployment-environment fit — operating consistency and output governance.
Future study directions, comparator logic, and intended-use evidence frameworks — clearly separated from internal evidence.
BIQADX programs are at research, prototype, and engineering-development stages. No device has been clinically validated and no regulatory approval has been obtained. The frameworks described are intended evidence architecture and research direction, not demonstrated analytical or clinical performance. ClinicalTrials.gov (NCT) identifiers, where ever referenced, are not FDA identifiers.
Evidence discipline
We claim that we have a rigorous, layered evidence framework designed to systematically validate every link in the diagnostic chain — from specimen integrity to reporting governance. We claim that our engineering development process is structured to generate the evidence needed for future regulatory submissions.
We do NOT claim that any device has been clinically validated. We do NOT claim that any result has been compared against a gold-standard reference method in a human-subject study. We do NOT claim regulatory approval from any authority. The frameworks described on this page are our intended evidence architecture — the standards we are building toward, not the evidence we have already generated.
A sophisticated partner or investor will recognise the difference between a company that describes its validation framework and one that implies it has already completed validation. We are the former, and we state so clearly.
Validation is not a supporting document behind the platform. It is part of the platform itself.